(Q54070929)

English

In-vitro activity of cefepime and other broad-spectrum antimicrobials against several groups of gram-negative bacilli and Staphylococcus aureus.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10579092

In-vitro activity of cefepime and other broad-spectrum antimicrobials against several groups of gram-negative bacilli and Staphylococcus aureus. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10579092

Staphylococcus aureus

1 reference

based on heuristic

inferred from title

author name string

Tallis E

1

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10579092

Rudensky B

2

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10579092

Attias D

3

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10579092

Raveh D

4

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10579092

Schlesinger Y

5

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10579092

Yinnon AM

6

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10579092

publication date

1 October 1999

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10579092

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10579092

35

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10579092

2

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10579092

121-126

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10579092

Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900062-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900062-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection and clinical significance of extended-spectrum beta-lactamases in a tertiary-care medical center

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900062-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levels

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900062-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900062-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900062-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900062-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibility of bacterial isolates to beta-lactam antibiotics from U.S. clinical trials over a 5-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900062-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of cefepime: a new extended-spectrum parenteral cephalosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900062-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of resistance during ceftazidime and cefepime therapy in a murine peritonitis model

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900062-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum β-lactamase (ESBL-KP) in the intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900062-0

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity of cefepime and ceftazidime against 197 nosocomial blood stream isolates of streptococci: a multicenter sample

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900062-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE)

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900062-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900062-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative activity of eight antimicrobial agents against clinical bacterial isolates from the United States, measured by two methods

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900062-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cefepime: a fourth-generation parenteral cephalosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900062-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Klebsiella bacteraemia: community versus nosocomial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900062-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0732-8893(99)00062-0

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10579092

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10579092

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54070929&oldid=1784456872"